BRCC3 Antikörper
Kurzübersicht für BRCC3 Antikörper (ABIN7465326)
Target
Alle BRCC3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Full length human BRCC36 Recombinant protein.
-
Isotyp
- IgG
-
-
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 14-316) antibody
BRCC3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316), (N-Term) antibodyBRCC3 Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal AT3B1 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 1-316) antibodyBRCC3 Reaktivität: Human WB, ELISA, IF, ICC Wirt: Maus Monoclonal AT3B1 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 36-70) antibodyBRCC3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB54401 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (AA 18-50) antibodyBRCC3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53911 unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) antibody (FITC)BRCC3 Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal FITC
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (C-Term) antibodyBRCC3 Reaktivität: Human, Maus, Ratte, Pferd, Schwein, Affe, Rind (Kuh), Meerschweinchen, Kaninchen, Fledermaus, Xenopus laevis WB Wirt: Kaninchen Polyclonal unconjugated
anti-BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3) (C-Term) antibodyBRCC3 Reaktivität: Human, Ratte, Pferd, Schwein, Affe, Fledermaus WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: A431
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- BRCC3 (BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3))
-
Andere Bezeichnung
- BRCA1/BRCA2-containing complex subunit 3
-
Hintergrund
- BRCA1/BRCA2-containing complex subunit 3 , BRCC36 , C6.1A , CXorf53,This gene encodes a subunit of the BRCA1-BRCA2-containing complex (BRCC), which is an E3 ubiquitin ligase. This protein is also thought to be involved in the cellular response to ionizing radiation and progression through the G2/M checkpoint. Alternative splicing results in multiple transcript variants. [provided by RefSeq]
-
Molekulargewicht
- 36 kDa
-
Gen-ID
- 79184
-
UniProt
- P46736
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Target
-
